XML 23 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash Flows from Operating Activities      
Net income from continuing operations $ 228,034 $ 354,268 $ 143,039
Adjustments to reconcile net income to net cash provided by (used in) continuing operating activities:      
Provision (benefit) for credit losses 60,066 27,426 62,774
Depreciation and amortization 27,157 21,667 18,514
Share-based compensation expense 14,150 13,860 12,883
Deferred taxes 6,907 17,754 (15,852)
Net amortization (accretion) of investment securities premiums and discounts 1,482 1,884 (443)
Unrealized (gain) loss on investment securities 710 (2,720) (1,447)
Net (gain) loss on sale of investment securities 23,164 (31,392) (20,078)
Loss on sale of foreign subsidiaries 0 2,840 0
Impairment loss on fixed assets and leases 1,362 0 0
Unrealized (gain) loss on derivatives (2,391) (3,208) 3,951
Loss on cash flow hedge derivative terminations 0 24,467 0
Settlement of terminated cash flow hedge derivatives 0 (27,156) 0
Fair value adjustment on loans held for sale 0 (1,115) 2,565
(Gain) loss on sale of loans (4,232) (12,855) (3,558)
Loss on sale of consumer installment loans 23,465 0 0
Origination and purchases of loans held for sale (366,496) (73,952) (74,828)
Proceeds from the sales and repayments of loans held for sale 59,594 65,241 72,999
Amortization (accretion) of loan net deferred fees, discounts and premiums (53,515) (222,693) (2,381)
Earnings on investment in bank-owned life insurance (15,697) (8,416) (7,009)
(Increase) decrease in accrued interest receivable and other assets (3,591) 46,655 (108,147)
Increase (decrease) in accrued interest payable and other liabilities (20,994) 102,985 50,436
Net Cash Provided by (Used in) Continuing Operating Activities (20,825) 295,540 133,418
Cash Flows from Investing Activities      
Proceeds from maturities, calls and principal repayments of investment securities available for sale 464,060 317,046 236,101
Proceeds from maturities, calls and principal repayments of investment securities held to maturity 59,507 0 0
Proceeds from sales of foreign subsidiaries 0 3,765 0
Proceeds from sales of investment securities available for sale 983,575 689,856 387,810
Purchases of investment securities available for sale (1,357,354) (3,626,377) (1,201,913)
Origination of mortgage warehouse loans (28,966,329) (55,034,537) (60,948,107)
Proceeds from repayments of mortgage warehouse loans 29,895,527 56,365,692 59,582,277
Net (increase) decrease in loans and leases, excluding mortgage warehouse loans (1,933,109) 1,652,994 (4,220,617)
Proceeds from sale of loans and leases 136,920 398,015 26,362
Purchases of loans (483,980) (1,907,222) (270,959)
Purchases of bank-owned life insurance 0 (46,462) 0
Proceeds from bank-owned life insurance 11,807 1,999 0
Net purchases of FHLB, Federal Reserve Bank, and other restricted stock (3,174)    
Net proceeds from sales of FHLB, Federal Reserve Bank, and other restricted stock   6,784 12,846
Purchases of bank premises and equipment (4,046) (613) (4,668)
Proceeds from sales of other real estate owned 0 45 97
Proceeds from sales of leased assets under lessor operating leases 7,485 10,092 0
Purchases of leased assets under lessor operating leases (109,301) (32,338) (24,124)
Net Cash Provided by (Used in) Continuing Investing Activities (1,298,412) (1,201,261) (6,424,895)
Cash Flows from Financing Activities      
Net increase (decrease) in deposits 1,379,029 5,467,995 2,660,993
Net increase (decrease) in short-term borrowed funds from the FHLB (400,000) (150,000) 0
Net increase (decrease) in federal funds purchased (75,000) (175,000) (288,000)
Net increase (decrease) in borrowed funds from PPP Liquidity Facility 0 (4,415,016) 4,415,016
Proceeds from long-term borrowed funds from the FHLB 500,000 0 0
Proceeds from issuance of other long-term borrowings 0 98,799 0
Repayments of other borrowings (100,000) 0 0
Redemption of preferred stock 0 (82,497) 0
Preferred stock dividends paid (9,326) (10,833) (14,076)
Purchases of treasury stock (33,162) (27,662) 0
Payments of employee taxes withheld from share-based awards (5,063) (5,568) (2,063)
Proceeds from issuance of common stock 533 27,762 923
Proceeds from sale of non-controlling interest in BMT 0 26,795 0
Net Cash Provided by (Used in) Continuing Financing Activities 1,257,011 754,775 6,772,793
Net Increase (Decrease) in Cash and Cash Equivalents From Continuing Operations (62,226) (150,946) 481,316
Discontinued Operations:      
Net cash provided by (used in) operating activities 0 (24,376) 18,605
Net cash provided by (used in) investing activities 0 0 (72)
Net cash provided by (used in) financing activities 0 0 (19,000)
Net Increase (Decrease) in Cash and Cash Equivalents From Discontinued Operations 0 (24,376) (467)
Net Increase (Decrease) in Cash and Cash Equivalents (62,226) (175,322) 480,849
Cash and Cash Equivalents – Beginning Balance 518,032 693,354 212,505
Cash and Cash Equivalents – Ending Balance 455,806 518,032 693,354
Supplementary Cash Flow Information:      
Interest paid 226,993 107,916 131,363
Income taxes paid 80,054 94,093 3,253
Noncash Operating and Investing Activities:      
Transfer of investment securities available for sale to held to maturity 500,174 0 0
Purchases of investment securities held to maturity upon sale of consumer installment loans 400,001 0 0
Distribution of investment in BM Technologies common stock 0 32,983 0
Transfer of loans held for investment to held for sale 4,079 0 74,050
Transfer of loans held for sale to held for investment 0 55,684 0
Transfer of multifamily loans held for sale to held for investment 0 0 401,144
Unsettled purchases of investment securities $ 0 $ 0 $ 2,244